SSY Group Ltd  

(Public, HKG:2005)   Watch this stock  
Find more results for 2005
-0.01 (-0.38%)
Delayed:   9:49AM GMT+8
HKG data delayed by 15 mins - Disclaimer
Currency in HKD
Range 2.63 - 2.66
52 week 1.69 - 2.82
Open 2.63
Vol / Avg. 218,000.00/3.05M
Mkt cap 7.54B
P/E 20.81
Div/yield 0.03/0.94
EPS 0.13
Shares 2.84B
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 18.97% 18.16%
Operating margin 26.09% 24.37%
EBITD margin - 33.82%
Return on average assets 8.41% 8.23%
Return on average equity 16.64% 14.29%
Employees 3,900 -
CDP Score - -


+85226880869 (Phone)
+85227873338 (Fax)

Website links


SSY Group Limited, formerly Lijun International Pharmaceutical (Holding) Co., Ltd., is an investment holding company. The Company, along with its subsidiaries, is engaged in the research, development, manufacturing and selling of a range of finished medicines and bulk pharmaceutical products to hospitals and distributors. The Company has manufacturing plants in Hebei Province and Shaanxi Province, the People's Republic of China and sells to customers principally in Mainland China. The Company's segments include intravenous infusion solution, and antibiotics and others. Its subsidiaries include New Orient Investments Limited, Shijiazhuang No.4 Pharmaceutical Co., Ltd., Xi'an Lijun Pharmaceutical Co., Ltd., Shenzhen Lijun Pharmaceutical Co., Ltd., Hebei Jin men Pharmaceutical Import & ExportCo., Ltd., Hebei Guolong Pharmaceutical Co., Ltd. and others.

Officers and directors

Jiguang Qu Executive Chairman of the Board, Chief Executive Officer
Age: 60
Hing Yeung Chow Chief Financial Officer, Company Secretary
Xuejun Su Executive Director
Age: 46
Xianjun Wang Executive Director
Age: 52
Kwok Wai Chow Independent Non-Executive Director
Age: 49
Chong Shun Leung Independent Non-Executive Director
Age: 51
Yibing Wang Independent Non-Executive Director
Age: 52